Followers | 149 |
Posts | 9,339 |
Boards Moderated | 7 |
Alias Born | 03/29/2017 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$TVOG Acquisition PR about to break early next week. Per tweet from CEO
$TVOG Acquisition PR about to break early next week. Per tweet from CEO
LV2 crazy thin. Need PR from home front. Good opportunity here .
I see Checkfan posting, I know he has vital info . Great find brother.
Agreed go4. Love looking @ the accumulation here. Peeps been loading.
Nice brother. $TVOG blasting off.
Per CEO, dilution will be almost non existent. Any commons will be restricted and tied 2 deal/management. Getting PPS ready 4 Nasdaq is their priority. Just going UP and UP.
Oops I thought you said it does. RS changes OS. It does not change AS.
Heavy accumulation last couple days with mega PR coming . Love it $TVOG
Bro RS does not change AS. They can change AS 2 whatever they voted on. The RS is for outstanding shares. I said that earlier.
I'm not going 2 assume what he will do with the preferred, but I doubt he will tarnish HLK name.. Which is huge.
https://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=tx227WOmULFrRlEAi3xT7w%253d%253d&nt7=0
http://cureconnect.org/portfolio-items/hlk-biotechnology-ltd/
http://www.hlkpharma.com/index.php/About/index
Nice! Could be coming tomorrow or latest Monday. They wouldn't update that unless its about 2 break. $TVOG bitumen tanker leaving port soon!
My man, Love your enthusiasm but RS was needed. AS was near maxed out. Why would they prepare all those filings and not RS a shell that was almost maxed out with a bloated OS? Paid money and time 4 filings so they could just keep all these shares trading between public? What would be their advantage?
Authorized Shares
4,925,000,000
a/o Aug 26, 2008
Outstanding Shares
4,624,573,155
a/o Nov 25, 2017
Excellent Jett.. That chart is insane.. This is gonna be a fun ride 4 us all. $TVOG
Nice finish today.. Broke milly mark on volume. Thinking we see PR Monday early morning but Friday could happen.
MVES safe bet 4 a good bounce bro. Plenty of catalysts that should be coming out with regards 2 Rainbow movie and App deal. These some good levels 2 grab more or set lower bids, either way I believe this bounces good @ some point soon.
That is part of the plan. $TVOG
Turner’s strategy includes a plan to expand from an initial bitumen tanker acquisitions to up to 30 tanker ships in the next 12-18 months in addition to targeting the purchasing/leasing of import/export facilities, asphalt refineries, distribution facilities, and related businesses.
Yes yes. See 1m today maybe. Gonna breakout like crazy when PR hits.
Runs with certain peeps involved will always fall like that. Proper PR here and its back on track. Thatll give you some juice.
$TGRR is a gem, I agree. Wouldn't take much 2 get this TIGER SHARK back on the hunt .
LV2 is T H I N. PR breaks and this would get crazy.
Yes brother. Uptick volume precursor 4 major major runs. PR inbound.
Think we should see info from company here soon.
Per IR, they are moving forward and hope 2 release information in the near future.
Yowza. Taking companies 2 Nasdaq... $50 million.. Liking what I am hearing.
I agree brother. Major loading going on. Per ceo, dilution will be minimal @ most. Intentions on OTCQB then to Nasdaq. $TVOG
Ask are very thin I do say. Bids @ 500k but also thin.
This will have its day, they are a different group running this show. They aren't trying to deceive or cash in.
I'm waiting on PR or info about funding, not band aid forbearance.
Agreed Rock. Impatient or just emptyheaded. $TVOG PR gonna start chase city.
Love it. I'm going back in the cookie jar myself
200k volume @ start. Words getting out.
ahha Nice brother. $TVOG when PR pops gonna GOOOOOOooooo
Seeing all the Nasdaq stocks NTFL help facilitate 2 market is incredible. $TVOG picked perfect partner.
I'm standing with ya. I saw RS coming and gladly was buying. Low float with merger coming lol, 1's on the menu.
Afterburners engaged!!!!!!!!!!
Think all of us have been grabbing major tickets . $RCHA party gonna pop.
Crazy news $RCHA. Big day coming.
UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials
12:35 pm ET December 5, 2017 (Globe Newswire) Print
Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology, today announced that it has retained IND 2 Results, LLC, (I2R) Atlanta Georgia, to serve as its Contract Research Organization (CRO).
I2R will work on protocol development, medical writing, and regulatory consulting for Rich as it plans to move forward with clinical trials in Hodgkin's Lymphoma (HL). Subsequently, the Company intends to have I2R assist in preparing the protocol for submission to the Food and Drug Administration (FDA).
In addition, I2R is assisting the Company in amending the Acute Myelocytic Leukemia (AML) protocol in preparation for the Submission Package to a major U.S. clinical site soon-to-be-named, and I2R will also prepare submission packages for the clinical site's Institutional Review Board (IRB). In cooperation with the clinical site, and subject to the receipt of adequate additional funding, Rich Pharmaceuticals plans to conduct a study for the treatment of AML in refractory patients in Phase I/II trial. AML is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that build up in the bone marrow and interfere with the production of normal blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. Because the incidence increases with age, it is expected that incidence will rise as population ages.
"I2R has a strong track record of success in conducting complicated clinical trials. Its multi-disciplinary team of experienced clinical trial professionals will work with Rich Pharmaceuticals as we move forward with our innovative treatment for lymphoma and leukemia," said Ben Chang, Rich Pharmaceuticals CEO. "We believe that getting a talented CRO team on board is an important step for our future."
LOL haha that's badass
Nice find Jett. They have been very successful in up listing and/or IPO's but had no idea this successful.. Nice man.
Like the sound of that Beer. Ive been fishing TVOG cheapies 4 the last two weeks. $TVOG
Nice. This deserves it. Could have an epic runner here.